June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Intraocular Lens Stabilisation with a novel implant: One year follow up in a cohort of 120 patients
Author Affiliations & Notes
  • Ioannis G Pallikaris
    EYEPCR B.V., Greece
    Panepistemio Kretes Iatrike Schole, Heraklion, Crete, Greece
  • Ahmed Elmassry
    Alexandria University Faculty of Medicine, Alexandria, Egypt
  • Onurcan Sahin
    EYEPCR B.V., Greece
  • Loukia Leonidou
    EYEPCR B.V., Greece
  • Manolis Modatsos
    EYEPCR B.V., Greece
  • Dimitris Liakopoulos
    EYEPCR B.V., Greece
  • Georgios Louca
    EYEPCR B.V., Greece
  • Harilaos Ginis
    EYEPCR B.V., Greece
  • Footnotes
    Commercial Relationships   Ioannis Pallikaris EYEPCR B.V., Code C (Consultant/Contractor), EYEPCR B.V., Code F (Financial Support), EYEPCR B.V., Code P (Patent); Ahmed Elmassry EYEPCR B.V., Code F (Financial Support); Onurcan Sahin EYEPCR B.V., Code C (Consultant/Contractor), EYEPCR B.V., Code P (Patent); Loukia Leonidou EYEPCR B.V., Code C (Consultant/Contractor); Manolis Modatsos EYEPCR, Code E (Employment); Dimitris Liakopoulos None; Georgios Louca None; Harilaos Ginis EYEPCR B.V., Code C (Consultant/Contractor), EYEPCR B.V., Code P (Patent)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 2868 – F0005. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ioannis G Pallikaris, Ahmed Elmassry, Onurcan Sahin, Loukia Leonidou, Manolis Modatsos, Dimitris Liakopoulos, Georgios Louca, Harilaos Ginis; Intraocular Lens Stabilisation with a novel implant: One year follow up in a cohort of 120 patients. Invest. Ophthalmol. Vis. Sci. 2022;63(7):2868 – F0005.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To present safety and efficacy, clinical and surgical observations regarding a novel intracapsular implant

Methods : Ongoing prospective study of 120 patients with 12 months follow-up. The novel implant (fixOflex, EYE-PCR, Netherlands) is a hydrophilic acrylic ring (9.8mm diameter, 1.7mm thickens) injected through a 2.4mm incision prior to the intraocular lens (IOL) implantation. The optic of the IOL is secured in the ring’s retainers. Patients were recruited following randomization at Alexandria El nour Eye Hospital. All patient received the same type of IOL (Tecnis ZCB00, J&J, NJ ).

Results : Mean best corrected visual acuity and spherical equivalent was 0.92 ± 0.15 and -0.76 ± 0.86 respectively, 6 months postoperatively.
Mean postoperative anterior chamber depth was 4.26 ± 0.53 mm at six months follow up. Endothelial cell dencity at six months postoperatively was within normal limits (2268±432) after cataract surgery. No anterior chamber reaction or IOP changes were observed. Mean time for ring implantation was 1 min and 9 sec. No serious adverse events were observed. No Posterior Capsule Opacification (PCO) was observed (120 cases 6 months follow-up, 59 patients 1 year follow-up).

Conclusions : FixOflex provides an open capsule space for fast and safe IOL implantation providing postoperative stabilisation. The ring and IOL positioning is easy to control while additional minor manipulations are rarely needed.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×